DNA X, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
DNA X, Inc. (SONM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 14.39 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-04-15
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was -227.61K shares.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 19.20K shares, a 82.55% decline year-over-year.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 187.80K shares, a 56.50% increase year-over-year.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 35.00K shares, a 97.21% decline year-over-year.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 14.39K shares, a 92.02% decline from fiscal 2023.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 180.30K shares, a 95.92% decline from fiscal 2022.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.41M shares.
- DNA X, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 0.00 shares, a 100.00% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | -227.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -208.41K shares derived: sum of 2 quarters · filed 2026-04-15 | -20.61K shares derived: sum of 3 quarters · filed 2026-04-15 | 14.39K shares 10-K · filed 2026-04-15 | 259.00K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 19.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 207.00K shares derived: sum of 2 quarters · filed 2024-11-13 | 242.00K shares 10-Q · filed 2024-11-13 | -1.06M shares derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-06-30 | 187.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 222.80K shares 10-Q · filed 2024-08-09 | -1.08M shares derived: sum of 3 quarters · filed 2025-03-31 | -969.90K shares derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-03-31 | 35.00K shares 10-Q · filed 2024-05-14 | -1.27M shares derived: sum of 2 quarters · filed 2025-03-31 | -1.16M shares derived: sum of 3 quarters · filed 2025-03-31 | -1.04M shares derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-12-31 | -1.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -1.19M shares derived: sum of 2 quarters · filed 2025-03-31 | -1.07M shares derived: sum of 3 quarters · filed 2025-03-31 | 180.30K shares 10-K · filed 2025-03-31 | 1.80M shares 10-K · filed 2024-03-27 |
| 2023-09-30 | 110.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 230.00K shares derived: sum of 2 quarters · filed 2023-11-14 | 1.48M shares 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | 120.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 1.37M shares 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 1.25M shares 10-Q · filed 2023-05-08 | ||||
| 2022-12-31 | 4.41M shares 10-K · filed 2024-03-27 | ||||
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-20 | ||||
| 2020-12-31 | -23.40K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-06-29 | -17.40K shares derived: sum of 2 quarters · filed 2022-06-29 | 2.60K shares 10-K/A · filed 2022-06-29 | 26.00K shares 10-K · filed 2021-03-18 | |
| 2020-09-30 | 6.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 26.00K shares 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | 20.00K shares 10-Q · filed 2020-08-12 | ||||
| 2019-12-31 | 998.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 998.64K shares derived: sum of 2 quarters · filed 2021-03-18 | 1.64M shares 10-K · filed 2021-03-18 | ||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 637.21K shares 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | 637.21K shares 10-Q · filed 2019-08-13 | ||||
| 2018-12-31 | 458.16K shares 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CLEARONE INC (CLRO) | United States | $0.009B | |
| FRANKLIN WIRELESS CORP (FKWL) | United States | $0.028B | -61.80 |
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |